发明人徐明华,唐晓军,胡光. "Method for the Synthesis of Ibrutinib Impurity 170" [P]. 中国发明专利, 专利号 CN 113375117 A, 授权公告日 2022-07-10.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,请询 C4X-106478】伊布替尼杂质170 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2025, 1820, (7), 4072-4090.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,请询 C4X-106478】伊布替尼杂质170 as an Impurity". Anal. Chem., 2025, 350, (3), 6224-6250.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 170 Using HRMS and NMR". J. Sep. Sci., 2021, 729, 7572-7584.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 【停用,请询 C4X-106478】伊布替尼杂质170 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2018, 1109, 1725-1746.